Assessing liver function using dynamic Gd‐EOB‐DTPA‐enhanced MRI with a standard 5‐phase imaging protocol

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Journal of Magnetic Resonance Imaging

• Publication date

  2013-05-01

• Fields of study

  Medicine, Engineering

• Identifiers
  DOI 10.1002/jmri.23907PMID 23086736
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Hypervascular hepatocellular carcinomas: detection with gadoxetate disodium-enhanced MR imaging and multiphasic multidetector CT

  2012cited by this paper
• UvA-DARE ( Digital Academic Repository ) Radiological aspects of portal vein embolization

  2012cited by this paper
• Combined quantification of liver perfusion and function with dynamic gadoxetic acid-enhanced MR imaging.

  2012cited by this paper
• Tracer kinetic modelling in MRI: estimating perfusion and capillary permeability

  2012cited by this paper
• Validity of perfusion parameters obtained using the modified Tofts model: A simulation study

  2011cited by this paper
• Diagnostic efficacy of gadoxetic acid-enhanced MRI for hepatocellular carcinoma and dysplastic nodule.

  2011cited by this paper
• Fundamentals of tracer kinetics for dynamic contrast‐enhanced MRI

  2011cited by this paper
• Assessment of liver function in primary biliary cirrhosis using Gd-EOB-DTPA-enhanced liver MRI.

  2010cited by this paper
• Liver functional reserve estimation: state of the art and relevance for local treatments

  2010cited by this paper
• Dynamic contrast-enhanced CT imaging of hepatocellular carcinoma in cirrhosis: feasibility of a prolonged dual-phase imaging protocol with tracer kinetics modeling

  2009cited by this paper
• Quantification of cerebral blood flow, cerebral blood volume, and blood–brain‐barrier leakage with DCE‐MRI

  2009cited by this paper
• Dynamic contrast-enhanced MR imaging of the liver: current status and future directions.

  2009cited by this paper
• Quantification of liver perfusion by dynamic magnetic resonance imaging: Experimental evaluation and clinical pilot study

  2009cited by this paper
• Assessment of hepatic extraction fraction and input relative blood flow using dynamic hepatocyte‐specific contrast‐enhanced MRI

  2009cited by this paper
• Cellular and molecular mechanisms of liver injury.

  2008cited by this paper
• Advanced liver fibrosis: diagnosis with 3D whole-liver perfusion MR imaging--initial experience.

  2008cited by this paper
• The safety of intra-abdominal surgery in patients with cirrhosis: model for end-stage liver disease score is superior to Child-Turcotte-Pugh classification in predicting outcome.

  2005cited by this paper
• Quantitation of differential renal blood flow and renal function using dynamic contrast‐enhanced MRI in rats

  2004cited by this paper
• Quantitative Evaluation of Liver Function with MRI Using Gd-EOB-DTPA

  2004cited by this paper
• Hepatic flow parameters measured with MR imaging and Doppler US: correlations with degree of cirrhosis and portal hypertension.

  2003cited by this paper
• Capillarization of the sinusoids in liver fibrosis: Noninvasive assessment with contrast‐enhanced MRI in the rabbit

  2003cited by this paper
• Separate analysis of asialoglycoprotein receptors in the right and left hepatic lobes using 99mTc‐GSA SPECT

  2003cited by this paper
• Prognosis of a large cohort of patients with hepatocellular carcinoma in a single European centre.

  2002cited by this paper
• Hepatic perfusion parameters in chronic liver disease: dynamic CT measurements correlated with disease severity.

  2001cited by this paper
• Contrast agents in magnetic resonance imaging of the liver: present and future.

  1998cited by this paper
• Age and platelet count: a simple index for predicting the presence of histological lesions in patients with antibodies to hepatitis C virus

  1997cited by this paper
• Liver tumors: comparison of MR imaging with Gd-EOB-DTPA and Gd-DTPA.

  1996cited by this paper
• Liver Perfusion Studied with Ultrafast CT

  1995cited by this paper
• Liver contrast media for magnetic resonance imaging. Interrelations between pharmacokinetics and imaging.

  1993cited by this paper
• Functional images of hepatic perfusion obtained with dynamic CT.

  1993cited by this paper
• Graphical Evaluation of Blood-to-Brain Transfer Constants from Multiple-Time Uptake Data

  1983cited by this paper

• Assessment of hepatic transporter function in rats using dynamic gadoxetate-enhanced MRI: a reproducibility study

  2024cites this paper
• Multi-phasic magnetic resonance imaging of hemodynamic interchanges in hepatocarcinogenesis

  2023cites this paper
• How Much Is Enough? A Surgical Perspective on Imaging Modalities to Estimate Function and Volume of the Future Liver Remnant before Hepatic Resection

  2023cites this paper
• Risk Stratification of Patients with Marginal Hepatic Functional Reserve Using the Remnant Hepatocyte Uptake Index in Gadoxetic Acid-Enhanced Magnetic Resonance Imaging for Safe Liver Surgery

  2023cites this paper
• Mathematical models for biomarker calculation of drug-induced liver injury in humans and experimental models based on gadoxetate enhanced magnetic resonance imaging

  2023cites this paper
• Role of Functional MRI in Liver SBRT: Current Use and Future Directions

  2022cites this paper
• Determination of hepatic extraction fraction with gadoxetate low‐temporal resolution DCE‐MRI‐based deconvolution analysis: validation with ALBI score and Child‐Pugh class

  2022cites this paper
• Quantitative evaluation of liver function with gadoxetic acid enhanced MRI: Comparison among signal intensity-, T1-relaxometry-, and dynamic-hepatocyte-specific-contrast-enhanced MRI- derived parameters

  2022cites this paper
• Concentrations and pharmacokinetic parameters of MRI and SPECT hepatobiliary agents in rat liver compartments

  2021cites this paper
• Correlation of radiomic features on dynamic contrast-enhanced magnetic resonance with microvessel density in hepatocellular carcinoma based on different models

  2021cites this paper
• Dynamic contrast-enhanced MRI perfusion quantification in hepatocellular carcinoma: comparison of gadoxetate disodium and gadobenate dimeglumine

  2021cites this paper
• Functional remnant liver volumetry using Gd-EOB-DTPA-enhanced magnetic resonance imaging (MRI) predicts post-hepatectomy liver failure in resection of more than one segment.

  2020cites this paper
• Gd-EOB-DTPA-enhanced MRI T1 relaxometry as an imaging-based liver function test compared with 13C-methacetin breath test

  2020cites this paper
• This is a repository copy of DCE-MRI for early prediction of response in hepatocellular carcinoma after TACE and sorafenib therapy: A pilot study . early prediction

  2020cites this paper
• Preoperative Remnant Liver Function Evaluation Using a Routine Clinical Dynamic Gd-EOB-DTPA-Enhanced MRI Protocol in Patients with Hepatocellular Carcinoma

  2020cites this paper
• Ex vivo gadoxetate relaxivities in rat liver tissue and blood at five magnetic field strengths from 1.41 to 7 T

  2020cites this paper
• Use of imaging to assess the activity of hepatic transporters

  2020cites this paper
• Non-Invasive Characterization of Liver Disease : By Multimodal Quantitative Magnetic Resonance

  2020cites this paper
• Application Value of Magnetic Resonance Perfusion Imaging in the Early Diagnosis of Rat Hepatic Fibrosis

  2019cites this paper
• Estimating liver function in a large cirrhotic cohort: Signal intensity of gadolinium-ethoxybenzyl-diethylenetriamine penta-acetic acid-enhanced MRI.

  2019cites this paper
• Model-inferred mechanisms of liver function from magnetic resonance imaging data: Validation and variation across a clinically relevant cohort

  2019cites this paper
• Child-Pugh Classification using Magnetic Resonance Imaging using Gadoxetic Acid-based Contrast Agent Compared with Indocyanine Green and 99mTc-galactosyl-human Serum Albumin Liver Scintigraphy

  2019cites this paper
• Dynamic contrast-enhanced MRI to assess hepatocellular carcinoma response to Transarterial chemoembolization using LI-RADS criteria: A pilot study.

  2019cites this paper
• DCE-MRI for Early Prediction of Response in Hepatocellular Carcinoma after TACE and Sorafenib Therapy: A Pilot Study

  2018cites this paper
• Vascular input function correction of inflow enhancement for improved pharmacokinetic modeling of liver DCE‐MRI

  2018influential citation
• Clinical Evaluation of Free-Breathing Contrast-Enhanced T1w MRI of the Liver using Pseudo Golden Angle Radial k-Space Sampling

  2018cites this paper
• Assessment of Liver Function Using Pharmacokinetic Parameters of Gd-EOB-DTPA: Experimental Study in Rat Hepatectomy Model

  2018cites this paper
• Imaging techniques to study drug transporter function in vivo.

  2018cites this paper
• A New Model for MR Evaluation of Liver Function with Gadoxetic Acid, Including Both Uptake and Excretion

  2018cites this paper
• Regional Radiation Dose-Response Modeling of Functional Liver in Hepatocellular Carcinoma Patients With Longitudinal Sulfur Colloid SPECT/CT: A Proof of Concept.

  2018cites this paper
• The role of dynamic contrast-enhanced MRI analysis of perfusion changes in hepatocellular carcinoma

  2018cites this paper
• Gd-EOB-DTPA based magnetic resonance imaging for predicting liver response to portal vein embolization

  2017cites this paper
• Hepatic function imaging using dynamic Gd‐EOB‐DTPA enhanced MRI and pharmacokinetic modeling

  2017cites this paper
• Contrast agents in dynamic contrast-enhanced magnetic resonance imaging

  2017cites this paper
• Gd-EOB-DTPA-enhanced MRI for evaluation of liver function: Comparison between signal-intensity-based indices and T1 relaxometry

  2017cites this paper
• Gd-EOB-DTPA-enhanced MRI for monitoring future liver remnant function after portal vein embolization and extended hemihepatectomy: A prospective trial

  2017cites this paper
• Accurate Estimation of Functional Liver Volume Using Gd-EOB-DTPA MRI Compared to MDCT/99mTc-SPECT Fusion Imaging.

  2017cites this paper
• Hepatic gadoxetic acid uptake as a measure of diffuse liver disease: Where are we?

  2017cites this paper
• BJRD15675 1..12

  2016cites this paper
• Chronic liver disease: Quantitative MRI vs CEUS-based microperfusion

  2016cites this paper
• Quantitative assessment of hepatic function: modified look-locker inversion recovery (MOLLI) sequence for T1 mapping on Gd-EOB-DTPA-enhanced liver MR imaging

  2016cites this paper
• Evaluation of Magnetic Resonance (MR) Biomarkers for Assessment of Response With Response Evaluation Criteria in Solid Tumors: Comparison of the Measurements of Neuroendocrine Tumor Liver Metastases (NETLM) With Various MR Sequences and at Multiple Phases of Contrast Administration

  2016cites this paper
• Semi-quantitative assessment of the presence and Child-Pugh class of hepatitis B related cirrhosis by using liver lobe-based dynamic contrast-enhanced MRI.

  2016cites this paper
• Age dependence of spleen- and muscle-corrected hepatic signal enhancement on hepatobiliary phase gadoxetate MRI

  2016cites this paper
• Vascular assessment of liver disease—towards a new frontier in MRI

  2016cites this paper
• Imaging-based evaluation of liver function: comparison of 99mTc-mebrofenin hepatobiliary scintigraphy and Gd-EOB-DTPA-enhanced MRI

  2015cites this paper
• Advanced fibrosis: Correlation between pharmacokinetic parameters at dynamic gadoxetate-enhanced MR imaging and hepatocyte organic anion transporter expression in rat liver.

  2015cites this paper
• Magnetic Resonance Imaging haemodynamic modelling in chronic liver disease: development, validation and translation

  2015cites this paper
• Assessment of liver function and liver fibrosis with dynamic Gd-EOB-DTPA-enhanced MRI.

  2015cites this paper
• Feasibility study of high-resolution DCE-MRI for glomerular filtration rate (GFR) measurement in a routine clinical modal.

  2015cites this paper
• The relationship between liver function and liver parenchymal contrast enhancement on Gd-BOPTA-enhanced MR imaging in the hepatocyte phase.

  2015cites this paper
• Consensus statements from a multidisciplinary expert panel on the utilization and application of a liver-specific MRI contrast agent (gadoxetic acid).

  2015cites this paper
• Efficacy of liver parenchymal enhancement and liver volume to standard liver volume ratio on Gd-EOB-DTPA-enhanced MRI for estimation of liver function

  2014cites this paper
• Hepatic necro-inflammation and elevated liver enzymes: evaluation with MRI perfusion imaging with gadoxetic acid in chronic hepatitis patients.

  2014cites this paper
• Evaluation of gadolinium-EOB-DTPA uptake after portal vein embolization: value of an increased flip angle

  2014cites this paper
• Characterising gadofosveset for use in quantitative MRI studies

  2013cites this paper
• Measuring hepatic functional reserve using low temporal resolution Gd-EOB-DTPA dynamic contrast-enhanced MRI: a preliminary study comparing galactosyl human serum albumin scintigraphy with indocyanine green retention

  2013cites this paper
• Gd-EOB-DTPA-enhanced MRI for the assessment of liver function and volume in liver cirrhosis.

  2013influential citation
• Non-Invasive Assessment of Liver Fibrosis with 31P-Magnetic Resonance Spectroscopy and Dynamic Contrast Enhanced Magnetic Resonance Imaging

  2013cites this paper
• Increase in left liver lobe function after preoperative right portal vein embolisation assessed with gadolinium-EOB-DTPA MRI

  2013cites this paper
• Design of novel protein-based MRI contrast agernets with high relaxivity and stabilty for biomedical imaging

  2013cites this paper